logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5153.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5153.produseast1
Showing 1 - 4 of 4 Items
Showing 1 - 4 of 4 Items
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Conference Material
|
Poster

Mortalité rétrospective et séroprévalence des anticorps anti-SARS-CoV-2 au Cameroun

Eyong J, Fai KN, Nikolay B, Gignoux EM, Nsaibirini R,  et al.
2024-05-23 • Epicentre Scientific Day 2024
2024-05-23 • Epicentre Scientific Day 2024
Journal Article
|
Research

Nationwide retrospective mortality and seroprevalence of SARS-CoV-2 antibodies in Cameroon

Eyong J, Fai KN, Nikolay B, Gignoux EM, Nsaibirini R,  et al.
2023-10-04 • Scientific African
2023-10-04 • Scientific African
BACKGROUND
Although the first year of the COVID-19 pandemic in Africa did not produce the expected catastrophe, the true impact of COVID-19 in the Cameroonian population was unclear....
Journal Article
|
Letter

On the importance and challenges of global access to proven life-saving treatments for Ebolavirus – Authors' reply

Torreele E, Boum Y, Adjaho I, Alé FGB, Issoufou SH,  et al.
2023-04-01 • Lancet Infectious Diseases
2023-04-01 • Lancet Infectious Diseases
Journal Article
|
Commentary

Breakthrough treatments for Ebola virus disease, but no access—what went wrong, and how can we do better?

Torreele E, Boum Y, Adjaho I, Alé FGB, Issoufou SH,  et al.
2023-01-19 • Lancet Infectious Diseases
2023-01-19 • Lancet Infectious Diseases
Three years since proving effective for Ebola virus disease in a clinical trial, two breakthrough treatments are registered and stockpiled in the USA but still not registered and general...